In briefBMJ 1998; 316 doi: https://doi.org/10.1136/bmj.316.7134.797a (Published 14 March 1998) Cite this as: BMJ 1998;316:797
Cheaper HIV drugs for developing world: GlaxoWellcome is to provide zidovudine at substantially reduced cost to pregnant women in the developing world who are HIV positive. The drug will be three to four times less expensive than in the West. A recent trial in Thailand in pregnant women infected with HIV showed that a short course of oral zidovudine during the last …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial